Phase 2 Stem Cell Study for ALS Approved – Monthly Prescribing Reference
|
Phase 2 Stem Cell Study for ALS Approved
Monthly Prescribing Reference Brain Storm Cell Therapeutics announced that the Phase 2 clinical trial of NurOwn for patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease, has received FDA approval to begin. NurOwn is an autologous, adult stem cell … |
